WPD Pharmaceuticals (XCNQ:WBIO) ROCE % : 0.00% (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. WPD Pharmaceuticals's annualized ROCE % for the quarter that ended in Jun. 2024 was 0.00%.

WPD Pharmaceuticals ROCE % Historical Data

The historical data trend for WPD Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals ROCE % Chart

WPD Pharmaceuticals Annual Data

Trend

Jan13

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-679.28

-120.09

1,279.81

WPD Pharmaceuticals Quarterly Data
	Apr19	Jul19	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

WPD Pharmaceuticals ROCE % Calculation

WPD Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	0	/	( ( (0.076 - 0.555)	+	(0.346 - 0.598) )	/ 2 )
	=	0	/	( (-0.479	+	-0.252)	/ 2 )
	=	0	/	-0.3655
	=	0.00 %

WPD Pharmaceuticals's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-0.012	/	( ( (0.276 - 0.668)	+	(0.273 - 0.608) )	/ 2 )
	=	-0.012	/	( ( -0.392	+	-0.335 )	/ 2 )
	=	-0.012	/	-0.3635
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

WPD Pharmaceuticals (XCNQ:WBIO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

WPD Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

8SV1:Germany

Address

700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8

Website

https://www.wpdpharmaceuticals.com

WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.

Executives

Constantine Carmichel

Director

WPD Pharmaceuticals Headlines

No Headlines